Item 1A. Risk Factors.

There were no material changes to the risk factors disclosed in our Annual Report on Form 10-K for the year ended December 31, 2021 and our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2022.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Our stock repurchase activity for each of the three months in the quarter ended September 30, 2022 was:


	Issuer Purchases of Equity Securities
Period	Total Number of Shares Purchased (1)	Average Price Paid per Share (1)		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (2)	Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs (2)
July 1-31, 2022	2,108,944	$	61.93	2,105,950	$	2,019
August 1-31, 2022	1,053,061	64.03		1,049,976	1,952
September 1-30, 2022	2,361,113	59.36		2,356,985	1,812
For the Quarter Ended September 30, 2022	5,523,118	$	61.23	5,512,911

(1)The total number of shares purchased (and the average price paid per share) reflects: (i) shares purchased pursuant to the repurchase program described in (2) below; and (ii) shares tendered to us by employees who used shares to exercise options and to pay the related taxes for grants of deferred stock that vested, totaling 2,994 shares, 3,085 shares and 4,128 shares for the fiscal months of July, August and September 2022, respectively.

(2)Dollar values stated in millions. As of September 30, 2022, our Board of Directors has authorized the repurchase up to $23.7 billion of our Common Stock through December 31, 2023. Since the program inception on March 12, 2013 through September 30, 2022, we have repurchased $21.9 billion, and as of September 30, 2202, we had approximately $1.8 billion share repurchase authorization remaining. See related information in Note 11, Stock Plans.

Previous: Item 4. Controls and Procedures. · Next: Item 6. Exhibits.